PRESS RELEASES

Date Title Report
24 Jan 11 Sale of generic pharmaceutical operations in Australia and Southeast Asia for AU$375 million - Analyst Presentation PDF 1.33 MB
24 Jan 11 Strides Arcolab Sells Its Generic Pharmaceutical Operations In Australia and Southeast Asia to Watson Pharmaceuticals for Au$ 375 Million. PDF 79 KB
Date Title Report
22 Dec 11 Strides Press Release Sterile Plant Approval and Fludarabine Approval. PDF 104 KB
15 Dec 11 Strides Press Release Cytarabine Approval. PDF 99 KB
24 Nov 11 Approval Momentum for Oncology Products Continues With Two More USFDA Approvals. PDF 106 KB
11 Nov 11 Strides Arcolab receives US FDA approval for Carboplatin Injection. PDF 178 KB
02 Nov 11 Strides Arcolab Receives US FDA Approval for Doxorubicin Injection. PDF 87 KB
24 Oct 11 Strides Results Pack Financials for Q3 '11. PDF 974 KB
24 Oct 11 Strides delivers Superior Q3 '2011 Financials Ups Full Year Guidance PDF 125 KB
20 Oct 11 Strides Arcolab Receives US FDA Approval For Bupivacaine Hydrochloride Injection, USP PDF 77 KB
10 Oct 11 Strides Arcolab Receives US FDA Approval for Cladribine Injection PDF 77 KB
03 Oct 11 Strides Arcolab Receives US FDA Approval For Clindamycin Injection, USP PDF 74 KB
30 Sep 11 Strides Oncology Approvals Gain Momentum With Two More USFDA Approvals PDF 88 KB
15 Sep 11 Strides Announces European Approval For Oxaliplatin Injection PDF 90 KB
14 Sep 11 Strides continued US FDA Approval Status For Oral Dosage Facility PDF 66 KB
28 July 11 Strides Arcolab Announces US FDA Approval For Acarbose Tablets PDF 106 KB
26 July 11 Strides Arcolab Announces US FDA Approval For Gemcitabine For Injection USP PDF 77 KB
1 July 11 Strides Announces European Approval For Its Oral Dosage Facility In Its Oncology Complex PDF 50 KB
1 July 11 Strides Arcolab Receives US FDA Approval For Polymyxin Injection PDF 50 KB
29 Jun 11 Strides Arcolab Joins The Malaysian BIO-XCELL Ecosystem PDF 50 KB
21 Jun 11 Strides Arcolab Receives US ADA Approval For Levofloxacin Injection PDF 50 KB
5 May 11 Strides Arcolab Receives US FDA Approval For Midazolam Injection Multi-Dose Vials PDF 50 KB
2 May 11 Strides announces US FDA approval for its Oncology facility in Bangalore PDF 50 KB
25 Apr 11 Results Pack Financials for Q1 2011 PDF 50 KB
25 Apr 11 Strides Announces Q1 ‘2011 Financial Results PDF 50 KB
18 Apr 11 Strides Arcolab Announces US FDA Approval For Its ‘New Sterile Injectable Facility PDF 50 KB
13 Apr 11 Strides Arcolab Receives US FDA Nod To Commercialize First Liquid Injectable Product From Its New Facility PDF 50 KB
4 Mar 11 Strides Announces First European Approval For Oncology Product PDF 50 KB
1 Mar 11 Strides arcolab receives US FDA nod to commercialize first sterile product from new facility PDF 50 KB
24 Feb 11 Results Pack Financials for the year 2010 PDF 50 KB
24 Feb 11 Press Release PDF 50 KB
20 Jan 11 AGILA Signs Agreement with Biochimico To Set Up A Joint Venture Company In Brazil. PDF 50 KB
18 Jan 11 Strides Arcolab announces US FDA Approval for additional Adenosine Injection USP PDF 50 KB
Date Title Report
10 Dec 10 Strides Arcolab Announces US FDA Approval for Lidocaine Hydrochloride Injection. PDF 50 KB
09 Dec 10 Strides acquires controlling stake in Inbiopro. PDF 50 KB
01 Dec 10 Strides Arcolab Announces US FDA Approval Of Midazolam Hydrochloride Injection. PDF 50 KB
25 Nov 10 Strides Specialties Rebranded As Agila Specialties. PDF 50 KB
29 Oct 10 Strides Arcolab receives ANDA approval from US FDA for Lamivudine and Zidovudine under PEPFAR scheme. PDF 50 KB
27 Oct 10 Strong Performance Across Business Divisions Steers 35% Growth In Revenue For Strides. PDF 50 KB
26 Oct 10 Strides' Generic Oseltamivir Receives WHO Prequalification for treatment of H1N1. PDF 50 KB
04 Oct 10 Strides Arcolab Records 50th Anda Approval 2 More Anda Approvals Received. PDF 50 KB
04 Aug 10 Strides Arcolab announces US FDA approval for Ergocalciferol Capsules 1.25mg first approval for a Soft Gelatine Product. PDF 50 KB
03 Aug 10 Strides' Sterile Carbapenems Facility In Campos, Brazil receives MHRA Approval. PDF 50 KB
30 Jul 10 Strides Arcolab Announces US FDA Approval of Sumatriptan Succinate Injection. PDF 50 KB
30 Jul 10 Strides Arcolab Announces US FDA Approval of Rocuronium Bromide Injection. PDF 50 KB
27 Jul 10 Strides today announced Q2-10 results. PDF 50 KB
13 Jul 10 Strides Annual Report 2009 Wins LACP Platinum Award. PDF 50 KB
18 May 10 Strides Arcolab Receives ANDA approval from US FDA for Abacavir Sulfate Tablets, 300mg under PEPFAR Scheme. PDF 50 KB
14 May 10 Strides and Pfizer Strengthen Partnership. PDF 50 KB
13 May 10 Strides Arcolab announces US FDA Approval of Vecuronium Bromide for Injection. PDF 50 KB
12 May 10 Strides Arcolab announces US FDA Approval Of Bacitracin For Injection, USP. PDF 50 KB
11 May 10 Manish Gupta to lead Pharma Business at Strides Arcolab. PDF 50 KB
22 Apr 10 Strides Arcolab Announces US FDA Tentative Approval Of Additional Adenosine Injection. PDF 50 KB
22 Apr 10 Strides today announced Q1'10 financials. PDF 50 KB
21 Apr 10 Strides Arcolab Announces US FDA Approval For Metoprolol Tartrate Injection. PDF 50 KB
20 Apr 10 Strides redeems USD 34 Million FCCBs due 2010. PDF 50 KB
19 Apr 10 Strides Arcolab Announces US FDA Approval For Mesna Injection. PDF 50 KB
14 Apr 10 Strides Arcolab Announces US FDA Approval For Granisetron Hydrochloride Injection. PDF 50 KB
18 Mar 10 Strides revises guidance upwards for FY 2010. PDF 50 KB
18 Mar 10 Strides and Aspen restructure Oncology arrangements. PDF 50 KB
04 Mar 10 Strides to acquire Campos facility in Brazil from Aspen. PDF 50 KB
24 Feb 10 Results Pack Financials for the year 2009. PDF 50 KB
24 Feb 10 Audited Financial Results for the Year ended 31 December 2009. PDF 50 KB
09 Feb 10 Strides Arcolab announces US FDA approval for Labetalol Hydrochloride injection, USP – total Approvals in sterile space at 18. PDF 50 KB
20 Jan 10 Strides Arcolab appoints Venkat Iyer To Board of Directors. PDF 50 KB
6 Jan 10 Pfizer and Strides Arcolab to Collaborate on Generic Products. PDF 50 KB
Date Title Report

Financial Results
11 Dec 09 Strides Arcolab Announces Conclusion of Court Process for Merger. PDF 50 KB
30 Oct 09 Strides Arcolab Limited today announced results of its limited review of financials for the third quarter ended September 30, 2009. PDF 50 KB
25 Sept 09 Strides Arcolab Announces The Retail Launch Of Starflu™ (Oseltamivir) For The Treatment Of 'Influenza – A (H1N1)' PDF 50 KB
01 Sept 09 Strides Arcolab Limited receives order from Government of India for the supply of Oseltamivir Capsules for the treatment of 'Influenza – A (H1N1)'. PDF 50 KB
11 Aug 09 Strides Arcolab Limited Fully geared to meet demand for supply of drugs for Influenza – A (H1N1) Pandemic. PDF 50 KB
30 Jul 2009 Strides Arcolab Limited today announced results of its limited review of financials for the second quarter ended June 30, 2009. PDF 50 KB
15 May 09 Strides Arcolab announces 2 ANDA approvals For Adenosine Injection USP and Meloxicam Tablets USP PDF 50 KB
05 May 09 Strides Arcolab Commences Commercial Supplies Of Oseltamivir Capsules For Influenza-A(H1n1) Virus (Swine Flu) PDF 50 KB
24 Apr 09 Financial Performance Q1-2009 PDF 50 KB
13 Apr 09 Strides Arcolab to align its Global Operations into 3 Separate entities Specialty Pharmaceuticals, Pharmaceuticals & R&D PDF 50 KB
13 Apr 09 Presentation on "Corporate Re-organization" For Press Release PDF 50 KB
08 Apr 09 Strides Arcolab receives NDA approval from US FDA for Lamivudine and Stavudine under PEPFAR scheme PDF 50 KB
27 Mar 09 Strides Arcolab announces US FDA approval for one more product PDF 50 KB
18 Mar 09 Strides Receives US FDA Inspection Approval Status for its Steriles Injectable Complex PDF 50 KB
25 Feb 09 Strides Arcolab Limited - FY-2008 Consolidated Highlights - Annexure - 1 A PDF 50 KB
25 Feb 09 Strides Arcolab Limited - FY-2008 Consolidated Highlights - Annexure - 1 B PDF 50 KB
25 Feb 09 Strides Arcolab Ltd., - Exceptional and Non Operational Items - Annexure 2 PDF 50 KB
25 Feb 09 Strides Arcolab Limited - Revenue Geographical Distribution - Annexure-3 PDF 50 KB
25 Feb 09 FY 2008 revenues up 49% to Rs.1,136 crores (USD 260 mio) PDF 50 KB
05 Jan 09 Balachandar to lead Human Resources at Strides PDF 50 KB
02 Jan 09 Strides Arcolab receives US FDA approval for two more products – Takes total Sterile product approvals to 14. PDF 50 KB
Date Title Report
3 Nov 08 Strides Arcolab receives US FDA approval for one more product – Takes total Sterile product approvals to 12. PDF 50 KB
31 Oct 08 Unaudited Consolidated Financial Results For The Quarter Ended September 30, 2008 PDF 50 KB
07 Oct 08 Strides Arcolab Receives US FDA Approval For Its Oral Dosage Form Facility, Bangalore PDF 50 KB
16 Sept 08 Strides Completes Business Rearrangement Consolidates Steps to Profitable Growth PDF 50 KB
02 Sept 08 Strides Arcolab receives US FDA approval for two more products PDF 50 KB
01 Aug 08 Strides completes acquisition of controlling interest in Ascent PDF 50 KB
23 Jul 08 Strides / Aspen Joint Venture In-Licensing Deal with GSK PDF 50 KB
22 Jul 08 Q2'08 Revenue up - 49% to Rs.2690 mn.[US$ 63 mn. PDF 50 KB
23 May 08 Strides Arcolab receives ANDA approval for Rifampicin for Injection USP, 600 mg / vial PDF 50 KB
16 May 08 Copy of Explanatory Memorandum being sent by Genepharm Australasia to its shareholders for seeking approval for issue of shares to Strides PDF 50 KB
14 May 08 Strides Arcolab receives ANDA approval for Flumazenil Injection USP, 0.1 mg/ml multiple dose vial PDF 50 KB
28 Apr 08 Strides & Genepharm signs definitive agreements Update on final transaction terms PDF 50 KB
24 Apr 08 Strides Arcolab receives 2 ANDA approvals for Ondansetron Injection USP, 2 mg/ml (20 ml vials) and 2 mg/ml (2 ml vials). PDF 50 KB
19 Mar 08 Strides Arcolab Receives its Third Injectable ANDA Approval for Fosphenytoin Injection 50mg/mL PDF 50 KB
12 Mar 08 Strides Arcolab Receives Cannada Approval for its Tazo Pip Injection PDF 50 KB
12 Mar 08 Strides Arcolab Receives US FDA Approval for its Penicillin Sterile Facility in Bangalore PDF 50 KB
11 Mar 08 Further to the press release issued by the company on 05 March 08 on Closure of Aspen transaction, the Strides Aspen JV today announced the following clarifications PDF 50 KB
05 Mar 08 Strides Arcolab-India and Aspen-South Africa Announce Successful Completion of the Latin American Transaction PDF 50 KB
08 Feb 08 Strides Arcolab, India and Genepharm, Australia Enter Into A Broad and Strategic Partnership For The Australasian Markets Through A Series of Transactions PDF 50 KB
09 Jan 08 Strides Arcolab Discontinues Manufacturing Operations in its New Jersey Facility PDF 50 KB